Otezla
NDC 55513-497, apremilast, tablet, film coated, from Amgen, Inc.
- Product NDC
- 55513-497
- Status
- Listed
- Labeler
- Amgen, Inc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205437
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55513-497 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- APREMILAST20 mg/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55513-497-60 | 55513049760 | 60 TABLET, FILM COATED in 1 BOTTLE (55513-497-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f6b1f516-4972-4d82-bced-113e47b41cc5NADAC price for package 55513049760
GET /v1/drugs/nadac/55513049760
Use it
Look up 55513-497 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55513-497 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55513-497. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.